Literature DB >> 34931605

Influence of nocturnal insomnia symptoms on obstructive sleep apnea diagnosis in a clinical referral cohort.

Ricardo L M Duarte1,2, Flavio J Magalhães-da-Silveira1, David Gozal3.   

Abstract

STUDY
OBJECTIVES: To assess whether nocturnal symptoms of insomnia influence the prevalence of obstructive sleep apnea (OSA) in a clinical referral cohort.
METHODS: Insomnia was defined by the presence of 1 or more of the following complaints: difficulty initiating sleep, difficulty maintaining sleep, and/or early morning awakenings. OSA severity was based on an apnea-hypopnea index: ≥ 5.0 events/h (any OSA), ≥ 15.0 events/h (moderate/severe OSA), and ≥ 30 events/h (severe OSA). Multivariate logistic regression analysis was used to evaluate predictive factors for OSA diagnosis and severity.
RESULTS: Overall, 12,021 outpatients referred for polysomnography were grouped into 2 cohorts: without insomnia (58.2%) and with insomnia (41.8%). Individuals without insomnia had a higher prevalence of OSA than those with insomnia (P < .001, for all OSA severity levels). The presence of insomnia was negatively associated with diagnosis of any OSA (adjusted odds ratio: 0.852; 95% confidence interval: 0.769-0.944), moderate/severe OSA (adjusted odds ratio: 0.819; 95% confidence interval: 0.751-0.892), and severe OSA (adjusted odds ratio: 0.816; 95% confidence interval: 0.746-0.892). Moreover, the number of nocturnal symptoms of insomnia was associated with a lower likelihood of OSA, even when adjusted for other confounders such as sex, age, body mass index, neck circumference, excessive daytime sleepiness, hypertension, and type 2 diabetes mellitus.
CONCLUSIONS: In this present study that included a large sample of consecutive outpatients, there was an inverse relationship between the number of nocturnal symptoms of insomnia and OSA diagnosis. CITATION: Duarte RLM, Magalhães-da-Silveira FJ, Gozal D. Influence of nocturnal insomnia symptoms on obstructive sleep apnea diagnosis in a clinical referral cohort. J Clin Sleep Med. 2022;18(5):1271-1278.
© 2022 American Academy of Sleep Medicine.

Entities:  

Keywords:  diagnosis; insomnia; obstructive sleep apnea; polysomnography; prevalence

Mesh:

Year:  2022        PMID: 34931605      PMCID: PMC9059600          DOI: 10.5664/jcsm.9842

Source DB:  PubMed          Journal:  J Clin Sleep Med        ISSN: 1550-9389            Impact factor:   4.324


  39 in total

Review 1.  Estimation of the global prevalence and burden of obstructive sleep apnoea: a literature-based analysis.

Authors:  Adam V Benjafield; Najib T Ayas; Peter R Eastwood; Raphael Heinzer; Mary S M Ip; Mary J Morrell; Carlos M Nunez; Sanjay R Patel; Thomas Penzel; Jean-Louis Pépin; Paul E Peppard; Sanjeev Sinha; Sergio Tufik; Kate Valentine; Atul Malhotra
Journal:  Lancet Respir Med       Date:  2019-07-09       Impact factor: 30.700

2.  Randomized controlled trial of an integrated approach to treating insomnia and improving the use of positive airway pressure therapy in veterans with comorbid insomnia disorder and obstructive sleep apnea.

Authors:  Cathy A Alessi; Constance H Fung; Joseph M Dzierzewski; Lavinia Fiorentino; Carl Stepnowsky; Juan C Rodriguez Tapia; Yeonsu Song; Michelle R Zeidler; Karen Josephson; Michael N Mitchell; Stella Jouldjian; Jennifer L Martin
Journal:  Sleep       Date:  2021-04-09       Impact factor: 5.849

3.  The relationship between obstructive sleep apnea and insomnia: a population-based cross-sectional polysomnographic study.

Authors:  B L Uhlig; K Hagen; M Engstrøm; M Stjern; G B Gravdahl; T Sand
Journal:  Sleep Med       Date:  2018-11-17       Impact factor: 3.492

4.  Consequences of comorbid insomnia symptoms and sleep-related breathing disorder in elderly subjects.

Authors:  Nalaka S Gooneratne; Philip R Gehrman; J Emeka Nkwuo; Scarlett L Bellamy; Sharon Schutte-Rodin; David F Dinges; Allan I Pack
Journal:  Arch Intern Med       Date:  2006-09-18

5.  Gender and ethnic differences in prevalence of self-reported insomnia among patients with obstructive sleep apnea.

Authors:  Shyam Subramanian; Bharat Guntupalli; Thirumagal Murugan; Swetha Bopparaju; Sreenivas Chanamolu; Lata Casturi; Salim Surani
Journal:  Sleep Breath       Date:  2010-10-16       Impact factor: 2.816

6.  Rules for scoring respiratory events in sleep: update of the 2007 AASM Manual for the Scoring of Sleep and Associated Events. Deliberations of the Sleep Apnea Definitions Task Force of the American Academy of Sleep Medicine.

Authors:  Richard B Berry; Rohit Budhiraja; Daniel J Gottlieb; David Gozal; Conrad Iber; Vishesh K Kapur; Carole L Marcus; Reena Mehra; Sairam Parthasarathy; Stuart F Quan; Susan Redline; Kingman P Strohl; Sally L Davidson Ward; Michelle M Tangredi
Journal:  J Clin Sleep Med       Date:  2012-10-15       Impact factor: 4.062

7.  Frequency of insomnia report in patients with obstructive sleep apnoea hypopnea syndrome (OSAHS).

Authors:  Simon Smith; Karen Sullivan; Wendy Hopkins; James Douglas
Journal:  Sleep Med       Date:  2004-09       Impact factor: 3.492

8.  Insomnia symptoms combined with nocturnal hypoxia associate with cardiovascular comorbidity in the European sleep apnea cohort (ESADA).

Authors:  Ulla Anttalainen; L Grote; I Fietze; R L Riha; S Ryan; R Staats; J Hedner; T Saaresranta
Journal:  Sleep Breath       Date:  2018-11-22       Impact factor: 2.655

9.  A Reappraisal on the Associations between Sleep-disordered Breathing, Insomnia, and Cardiometabolic Risk.

Authors:  Miguel Meira E Cruz; Cristina Salles; David Gozal
Journal:  Am J Respir Crit Care Med       Date:  2021-06-15       Impact factor: 21.405

10.  Gender differences of clinical and polysomnographic findings with obstructive sleep apnea syndrome.

Authors:  Xiaobo Zhou; Bo Zhou; Zhe Li; Qiao Lu; Shaoping Li; Zhongyin Pu; Fang Luo
Journal:  Sci Rep       Date:  2021-03-15       Impact factor: 4.379

View more
  1 in total

Review 1.  More than sleepiness: prevalence and relevance of nonclassical symptoms of obstructive sleep apnea.

Authors:  Johan Verbraecken
Journal:  Curr Opin Pulm Med       Date:  2022-09-14       Impact factor: 2.868

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.